China's clinical trial system now outpaces the U.S., exposing regulatory delays that ripple into supply planning, manufacturing windows, and drug development speed.
- Site-Level Execution In Clinical Trials: Where Systems Break Down
- Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC
- Truth: Clinical Supply Is Often The First To See The Whole Picture
- The $122 Billion Question: Can Clinical Trial Supply Systems Keep Pace With Cell Therapy Demand?
- From Individual Shipments To Patterns: How Compliance Is Understood Over Time
- Geopolitical Risk Is Reshaping Clinical Trial Supply Chains
- How Real-World, Real-Time, And Synthetic Data Are Revolutionizing Clinical Trial Supply Chains
- The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Building Clinical Supply Agility In A Changing Trial Landscape
Rising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
Building Robust Clinical Supply Chains To Support Global Trials
Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
IMP Labeling: EU CTR Transition Considerations
Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.
-
A Practical Packaging Components Checklist For Emerging Biotechs
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
Winning The Race To FPI With Early Randomization And Trial Supply Management
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
Key Considerations For Selecting Flexible Fillers
Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
Rethinking RTSM Software: When Bigger Isn't Better
Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
Why Advanced cGMP Manufacturing Is Key to Pharma Success
Advanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.